Jerzy Wojnar

905 total citations
56 papers, 620 citations indexed

About

Jerzy Wojnar is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Jerzy Wojnar has authored 56 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 19 papers in Immunology and 12 papers in Oncology. Recurrent topics in Jerzy Wojnar's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Lymphoblastic Leukemia research (10 papers) and Acute Myeloid Leukemia Research (9 papers). Jerzy Wojnar is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Lymphoblastic Leukemia research (10 papers) and Acute Myeloid Leukemia Research (9 papers). Jerzy Wojnar collaborates with scholars based in Poland, Germany and Hungary. Jerzy Wojnar's co-authors include Jerzy Hołowiecki, Tomasz Francuz, Mirosław Markiewicz, Sebastian Giebel, Małgorzata Krawczyk‐Kuliś, Enrique Gallego-Colón, Sławomira Kyrcz‐Krzemień, Jerzy Chudek, Grzegorz Helbig and Tomasz Czerw and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and British Journal of Haematology.

In The Last Decade

Jerzy Wojnar

54 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerzy Wojnar Poland 16 284 277 128 106 80 56 620
J. G. Smith United Kingdom 14 212 0.7× 153 0.6× 73 0.6× 151 1.4× 78 1.0× 38 488
Chu‐Myong Seong South Korea 14 245 0.9× 135 0.5× 155 1.2× 254 2.4× 127 1.6× 35 691
Meili Ge China 14 360 1.3× 261 0.9× 81 0.6× 93 0.9× 177 2.2× 69 630
Cristina Gonçalves Portugal 11 213 0.8× 91 0.3× 83 0.6× 93 0.9× 159 2.0× 41 499
Maria Marta Minervini Italy 16 283 1.0× 195 0.7× 76 0.6× 145 1.4× 243 3.0× 29 647
Xingxin Li China 13 308 1.1× 230 0.8× 74 0.6× 123 1.2× 125 1.6× 49 588
Jolanta Libura United States 9 153 0.5× 160 0.6× 242 1.9× 200 1.9× 43 0.5× 13 585
Daniele Sorcini Italy 10 173 0.6× 188 0.7× 171 1.3× 366 3.5× 50 0.6× 20 738
Barbara Wysoczańska Poland 13 165 0.6× 242 0.9× 105 0.8× 235 2.2× 47 0.6× 28 654
Yingqi Shao China 12 256 0.9× 197 0.7× 59 0.5× 91 0.9× 134 1.7× 53 492

Countries citing papers authored by Jerzy Wojnar

Since Specialization
Citations

This map shows the geographic impact of Jerzy Wojnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Wojnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Wojnar more than expected).

Fields of papers citing papers by Jerzy Wojnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy Wojnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Wojnar. The network helps show where Jerzy Wojnar may publish in the future.

Co-authorship network of co-authors of Jerzy Wojnar

This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Wojnar. A scholar is included among the top collaborators of Jerzy Wojnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Wojnar. Jerzy Wojnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wojnar, Jerzy, et al.. (2021). Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer. International Journal of Molecular Sciences. 23(1). 124–124. 20 indexed citations
2.
Francuz, Tomasz, et al.. (2020). Serum cytokine profile as a potential prognostic tool in colorectal cancer patients – one center study. Reports of Practical Oncology & Radiotherapy. 25(6). 867–875. 20 indexed citations
3.
Nowara, Elżbieta, et al.. (2016). Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia. Postępy Higieny i Medycyny Doświadczalnej. 70(0). 534–541. 10 indexed citations
4.
Francuz, Tomasz, et al.. (2016). The role of inflammation in colon cancer pathogenesis. Postępy Higieny i Medycyny Doświadczalnej. 70. 360–366. 17 indexed citations
5.
Wojnar, Jerzy, et al.. (2016). Osteoid Osteoma - Diagnostic and Therapeutic Difficulties. A. Single-centre Experience. Ortopedia Traumatologia Rehabilitacja. 18(2). 131–140. 2 indexed citations
6.
Wojnar, Jerzy, et al.. (2016). Galectins in hematological malignancies – role, functions and potential therapeutic targets. Postępy Higieny i Medycyny Doświadczalnej. 70. 95–103. 3 indexed citations
7.
Wojnar, Jerzy. (2011). Management of bleeding complications in patients with acute coronary syndrome – interdisciplinary problem. Hematologist’s comment. 8(4). 472–474. 1 indexed citations
8.
Giebel, Sebastian, Tomasz Czerw, Jerzy Wojnar, et al.. (2010). Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT. Bone Marrow Transplantation. 45(6). 1022–1030. 19 indexed citations
9.
10.
Wojnar, Jerzy, et al.. (2007). Prediction of Nonrelapse Mortality for Patients Surviving 100 Days After Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation Proceedings. 39(10). 3375–3379. 6 indexed citations
11.
Czerw, Tomasz, et al.. (2007). Beta-2-Microglobulin Level Predicts Outcome Following Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma. Transplantation Proceedings. 39(9). 2893–2897. 9 indexed citations
12.
Giebel, Sebastian, Izabela Nowak, Jerzy Wojnar, et al.. (2006). Impact of Activating Killer Immunoglobulin-like Receptor Genotype on Outcome of Unrelated Donor–Hematopoietic Cell Transplantation. Transplantation Proceedings. 38(1). 287–291. 30 indexed citations
13.
Giebel, Sebastian, et al.. (2006). Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe aplastic anemia.. PubMed. 11(2). 23–7; discussion 32. 7 indexed citations
14.
Giebel, Sebastian, Jerzy Wojnar, Małgorzata Krawczyk‐Kuliś, et al.. (2005). The impact of immunosuppressive therapy on an early quantitative NK cell reconstitution after allogeneic haematopoietic cell transplantation.. PubMed. 10(2). 29–33. 9 indexed citations
15.
Zaucha, Jan Maciej, Witold Prejzner, Sebastian Giebel, et al.. (2005). Imatinib therapy prior to myeloablative allogeneic stem cell transplantation. Bone Marrow Transplantation. 36(5). 417–424. 30 indexed citations
16.
Hołowiecki, Jerzy, Sebastian Grosicki, Maria Saduś‐Wojciechowska, et al.. (2005). Addition of Cladribine to Induction/Consolidation Regimen Does Not Impair Peripheral Blood Stem Cell Mobilization and Bone Marrow Harvest for Autotransplantation in Acute Myeloid Leukemia Patients. Transplantation Proceedings. 37(10). 4482–4487. 2 indexed citations
17.
Wojnar, Jerzy, et al.. (2005). Ryzyko utraty płynności jednostek samorządu terytorialnego-próba kwantyfikacji. 37–53. 2 indexed citations
18.
Markiewicz, Mirosław, Jerzy Hołowiecki, Jerzy Wojnar, et al.. (2004). Allogeneic transplantation of selected peripheral CD34+ cells with controlled CD3+ cells add-back in high-risk patients. Transplantation Proceedings. 36(10). 3194–3199. 1 indexed citations
19.
Hołowiecki, Jerzy, Małgorzata Wojciechowska, Sebastian Giebel, et al.. (2000). Ifosfamide, etoposide, epirubicine, and G-CSF: an effective mobilization regimen for PBSCT in heavily pretreated patients. Transplantation Proceedings. 32(6). 1412–1415. 5 indexed citations
20.
Wojnar, Jerzy & Z Kalina. (1987). [Ultrasonographic studies in evaluating the degree of advancement of stomach cancer].. PubMed. 42(27-28). 849–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. G. Smith Breakdown of academic impact, for papers by Chu‐Myong Seong Breakdown of academic impact, for papers by Meili Ge Breakdown of academic impact, for papers by Cristina Gonçalves Breakdown of academic impact, for papers by Maria Marta Minervini Breakdown of academic impact, for papers by Xingxin Li Breakdown of academic impact, for papers by Jolanta Libura Breakdown of academic impact, for papers by Daniele Sorcini Breakdown of academic impact, for papers by Barbara Wysoczańska Breakdown of academic impact, for papers by Yingqi Shao
Rankless by CCL
2026